We have located links that may give you full text access.
Journal Article
Review
Current synthetic notions on aspirin induced asthma.
Biomedicine & Pharmacotherapy 1999 August
Aspirin was discovered by Gerhardt in 1853. The first examples of its negative side-effects in the form of asthma like dyspnea were described as early as 1911 by Gilbert, and then by Reeds and by Cookes. Widal depicted the typical symptomatic triad of aspirin-associated illness in 1922, with the symptoms 'nasal polyposis, severe asthma, and intolerance to aspirin'. The role of inhibition of the cyclooxygenase was highlighted in the physiopathologic interpretation of the diseases in 1975. Since then, great progress has been made not only in the analysis of the disease, but also in the way to treat it that has been performed thanks to a new approach in the relative positions of 'nose bronchi' that enables the development of a new strategy in the relation between 'nasal and chest specialists'. If the mean of immuno-allergologic investigations, and particularly the scanographic and endoscopic imaging, have enabled a better cure for 'illness due to aspirin', it is nevertheless the case that this illness remains cortico-dependent too often. Important progress has been expected since the discovery of anti-leukotriens and several teams apparently emphasize how useful anti-leukotriens are in the control of aspirin-associated illness. Thus, this enables one to hope for a decrease in the first effective dose of corticosteroids and ever for the total elimination thereof.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app